GlobeNewswire by notified

Syrians Seek UN Rights Ruling Against Russia for 2019 Hospital Attacks

Share

Open Society Justice Initiative Files Complaint to the UN Human Rights Committee

New York, May 02, 2024 (GLOBE NEWSWIRE) -- The Russian Federation has been accused before the UN Human Rights Committee in Geneva of carrying out a deliberate attack on a hospital in Syria—in a legal action that highlights Moscow’s repeated use of military force against health care facilities in Syria, where its forces have been supporting the regime of President Bashar al-Assad.

A complaint before the Committee, filed on May 1, focuses on a series of air strikes on Kafr Nabl Surgical Hospital in Idlib province on May 5, 2019.

It accuses the Russian Air Force of killing two civilians and endangering the lives of all those working in and using the hospital at the time—medical practitioners, patients, support staff, and visitors.

The complaint has been brought before the Committee by a Syrian man whose two cousins were killed by the attack, and by Hand in Hand for Aid and Development, the humanitarian NGO that was supporting the hospital at the time. Hand in Hand is representing the interests of the patients of the hospital.

The applicants are represented by lawyers of the Open Society Justice Initiative, with Professor Philip Leach, professor of human rights law at the UK’s Middlesex University as co-counsel.

The evidence being presented to the Committee includes a detailed account of the Russian Air Force attack on the hospital at Kafr Nabl, and on three other hospitals near Kafr Nabl in just 12 hours on May 5-6, 2019. There was no fighting near the hospital at the time of the attack, which lay in opposition-controlled territory some 20km away from the front line.

The complaint draws on a wealth of video and audio recordings made at the time, as well as eyewitness accounts that point to direct Russian Air Force involvement in coordinating and executing the attacks. The material includes observations of Russian aircraft in the area at the relevant time, and audio recordings of communications between a Russian pilot and Russian ground control, authorizing the release of aerial munitions and confirming that the aerial munitions had been dropped, at the precise times that strikes were captured on video. Some of the material included as evidence in the complaint was used by the New York Timesin a special report published on October 13, 2019.

Fadi al-Dairi, the director of Hand in Hand, said: “The Russian air force attack on Kafr Nabl hospital was a well-documented atrocity that was part of a systematic assault on hospitals and healthcare facilities in opposition-held territory in Syria in 2019. The coordinates of the hospital had been shared with Russia by the UN under the UN Deconfliction Mechanism. Syrians are looking to the Human Rights Committee to show us some measure of redress by acknowledging the truth of this brutal attack, and the suffering caused."

James A. Goldston, executive director of the Justice Initiative, said: “This complaint before a preeminent international human rights tribunal exposes the Russian government and armed forces’ deliberate strategy of targeting healthcare in clear violation of the laws of war. It must remind us all that attacks on protected healthcare facilities—whether in Syria, Sudan, Ukraine, or the Gaza Strip—are an abomination that must never be normalized.”

The complaint is being supported by expert analyses prepared by Syrian Archive and Physicians for Human Rights. Physicians for Human Rights has documented 604 attacks against medical facilities in Syria since 2011, the overwhelming majority conducted by Syrian and Russian forces.

Houssam al-Nahhas, MD, Middle East and North Africa Researcher for Physicians for Human Rights, said: "Widespread and systematic attacks on health care in Syria are part of a strategy implemented by the Syrian and Russian governments, devastating the country’s health care system. Despite the seriousness of these crimes, no perpetrators have ever faced accountability. We hope this landmark case helps to end the impunity for attacks on health care in Syria and serve as a warning to perpetrators in other conflicts around the world."

The Geneva-based Human Rights Committee is a body of 18 independent experts that monitors implementation of the International Covenant on Civil and Political Rights (ICCPR), which has been signed by 173 countries. Under the ICCPR’s Optional Protocol, which the Russian Federation signed in 1990, individuals can bring complaints against signatory states before the Committee over rights violations.

The complaint accuses the Russian Federation of perpetrating a clear and serious violation of International Humanitarian Law by deliberately attacking a protected medical facility, in breach of the Right to Life under the ICCPR. The attack killed two brothers and endangered the lives of everyone working in and using the busy hospital. The hospital was operating normally at the time of the attack and neither Russia nor Syria provided any warning before the attack. This is not the only time the facility was targeted: Kafr Nabl Hospital was attacked 13 times between 2014 and 2019.

From a legal perspective, a decision against Russia would provide significant new jurisprudence on the extraterritorial obligations of States in armed conflict, and would pave the way for progressive decisions from other human rights bodies and courts.

The Open Society Justice Initiative is part of the Open Society Foundations, and pursues strategic litigation on a range of issues including advancing human rights and advancing the rule of law. Its work on Syria has included supporting efforts to bring top Syrian officials and leaders to trial before national courts in Europe for crimes against humanity committed in Syria.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

First quarter 2024 results: SCOR starts 2024 with a strong first three-months net income of EUR 196 million17.5.2024 07:30:54 CEST | Press release

Press release 17 May 2024 - N° 07 First quarter 2024 results SCOR starts 2024 with a strong first three-months net income of EUR 196 million Group net income of EUR 196 million in Q1 2024 (EUR 176 million adjusted1) Group Economic Value2 under IFRS 17 of EUR 9.6 billion as of 31 March 2024, up +4.8%3 (+4.1% at constant economics3,4) compared with 31 December 2023, implying an Economic Value per share of EUR 54 (vs. EUR 51 as of 31 December 2023) Estimated Group solvency ratio of 215%5 as of 31 March 2024Annualized Return on Equity of 17.3% (15.5% adjusted1) in Q1 2024 Insurance revenue of EUR 4,113 million in Q1 2024 (+6.0%6 compared to Q1 2023)P&C combined ratio of 87.1% in Q1 2024 (+1.9pts compared to Q1 2023)L&H insurance service result7 of EUR 72 million in Q1 2024 (EUR -200 million compared to Q1 2023) Investments regular income yield of 3.5% in Q1 2024 (+0.7pts compared to Q1 2023) SCOR SE’s Board of Directors met on 16 May 2024, under the chairmanship of Fabrice Brégier, to appr

Constellation Brands to Present at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 202416.5.2024 22:30:20 CEST | Press release

VICTOR, N.Y., May 16, 2024 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today that Bill Newlands, President and Chief Executive Officer, and Garth Hankinson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Bernstein 40th Annual Strategic Decisions Conference on Wednesday, May 29, 2024 in New York, NY. The presentation is scheduled to begin at 2:30 p.m. EDT and is expected to cover the company’s strategic business initiatives, financial metrics, and operating performance, as well as outlook for the future. A live, listen-only webcast of the presentation will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the presentation begins, financial information discussed in the presentation, and a reconciliation of reported GAAP financial measures with comparable and other non-GAAP financial measures, will also be available

DBV Technologies Announces Results of its 2024 Combined General Meeting16.5.2024 22:30:00 CEST | Press release

Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting (the “General Meeting”). The General Meeting was chaired by Michel de Rosen, Chairman of the Company. The Company’s shareholders approved all resolutions submitted by the Board of Directors. These resolutions and their results are posted on the Investors/Annual General Meetings section of the Company’s website: https://dbv-technologies.com/events/2024-annual-general-meeting/. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with sign

Clean Motion AB delårsredogörelse för januari-mars 202416.5.2024 22:10:00 CEST | Pressemelding

Elfordonstillverkaren Clean Motion AB presenterar sin delårsrapport för januari-mars 2024. Bolaget redovisar en försäljning på 38 (45) TSEK och ett rörelseresultat exklusive avskrivningar (EBITDA) på -2 949 (-1 825) TSEK. Bolaget meddelar även att ett licensavtal är tecknat för tillverkning av Zbee i Indien samt att deras nya produktionslokal för EVIG i Jonsered nu är godkänd. Sofia Haby, VD kommenterar; ”Vi har jobbat intensivt under kvartalet med både typgodkännande-processen och flytt till nya lokaler. Kvartalet har präglats av de förseningar som vi drabbats av med vårt typgodkännande, vilket förhindrat försäljning i Europa. Jag kan nu med glädje meddela att det mest kritiska testet blev godkänt igår kväll! Under de senaste månaderna har vi jobbat med att färdigställa vår nya produktionslokal i Jonsered. Jag är övertygad om att vi genom att samla alla resurser under ett tak, kommer att åstadkomma stora effektivitetsförbättringar. Teamet har arbetat dedikerat med att säkerställa en s

Galapagos creates new subscription right plans16.5.2024 22:01:00 CEST | Press release

Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024 RMV,” intended for the employees of its French subsidiary, Galapagos SASU, and “Subscription Right Plan 2024 ROW”, primarily intended for the employees of its other non-Belgian subsidiaries, within the framework of the authorized capital. Under these subscription right plans, 1,614,000 subscription rights were created, subject to acceptances, and offered to the beneficiaries of the plans. The subscription rights have an exercise term of eight years as of the date of the offer and have an exercise price of €

HiddenA line styled icon from Orion Icon Library.Eye